Increasing Age and Survival after Orthotopic Liver Transplantation for Patients with Hepatocellular Cancer

Abstract

Although OS was prolonged in younger patients who underwent OLT for HCC, there was no observed difference in disease-specific survival among the age groups. Our results suggest that carefully selected patients 65 years of age and older can derive equal benefit from OLT for HCC when compared with their younger counterparts.